CD274 and neoplasm: The PD-L1 quantification of the tumor specimens by the physician and the digital algorithm showed the same result in terms of positivity versus negativity in 99 (63.5%) of the analyzed patients, with 49 tumors (31.4%) classified as PD-L1 positive and 50 tumors (32.1%) as PD-L1 negative.